Physician profile
William J Oneill
NPI 1619971017
$518.12
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $231 · 2021: $35.76 · 2022: $112.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $223.21 | 2019-2022 | |
| Kerecis Limited | $101.77 | 2020 | |
| Zimmer Biomet Holdings, INC. | $53.72 | 2019 | |
| Arthrosurface Incorporated | $24.18 | 2019 | |
| Organogenesis INC. | $21.04 | 2021 | |
| Smith+Nephew, INC. | $20.51 | 2019 | |
| Grt US Holding, INC. | $15.90 | 2020 | |
| Kci USA, INC. | $15.52 | 2020 | |
| Tactile Systems Technology INC | $14.72 | 2021 | |
| Osiris Therapeutics INC. | $14.09 | 2019 | |
| Merck Sharp & Dohme LLC | $13.46 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Oneill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.